Evolent Health, Inc. EVH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.57M | -28.36M | -26.63M | -429.13M | -20.86M |
| Total Depreciation and Amortization | 15.69M | 15.77M | 15.76M | 39.34M | 18.02M |
| Total Amortization of Deferred Charges | 9.82M | 9.87M | 9.68M | 9.83M | 11.14M |
| Total Other Non-Cash Items | 15.70M | 18.79M | 11.74M | 392.30M | 18.91M |
| Change in Net Operating Assets | 8.73M | -25.38M | -11.53M | 36.46M | -11.39M |
| Cash from Operations | 26.38M | -9.31M | -984.00K | 48.80M | 15.81M |
| Capital Expenditure | -7.21M | -6.85M | -6.41M | -9.16M | -8.96M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 91.31M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 150.00K | 150.00K | -- | 0.00 | 198.00K |
| Cash from Investing | -7.06M | -6.70M | -6.41M | 82.15M | -8.76M |
| Total Debt Issued | -- | -- | -- | 18.31M | 168.74M |
| Total Debt Repaid | 0.00 | -10.00M | -- | -113.73M | -166.76M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.31M | -7.00K | -1.82M | -58.00K | -40.54M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 0.00 | -1.93M |
| Other Financing Activities | -3.24M | -986.00K | -2.16M | 2.44M | -1.33M |
| Cash from Financing | -4.55M | -10.99M | -3.97M | -93.04M | -41.82M |
| Foreign Exchange rate Adjustments | -381.00K | -274.00K | -589.00K | -225.00K | -201.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.39M | -27.28M | -11.95M | 37.69M | -34.97M |